ATV:BACE1/Tau

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameATV:BACE1/Tau

Drug Alias Nameantibodies (Denali)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionBeta-secretase 1 inhibitorsMicrotubule-associated protein tau inhibitors

TargetsMicrotubule-associated protein tauBeta-secretase 1

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesDenali Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesDenali Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A